Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 12,473 | 10,038 | 14,535 | 17,348 | 12,850 |
| Cost of Goods | 1,537 | 1,485 | 1,927 | 2,273 | 1,579 |
| Gross Profit | 10,936 | 8,553 | 12,608 | 15,075 | 11,271 |
| Operating Expenses | 11,066 | 10,337 | 13,317 | 13,921 | 13,566 |
| Operating Income | 407 | -1,299 | 218 | 1,427 | -1,716 |
| Interest Expense | 1,285 | 1,351 | 1,292 | 1,173 | 1,232 |
| Other Income | 267 | 109 | -81 | 51 | -115 |
| Pre-tax Income | -611 | -2,541 | -1,155 | 305 | -3,063 |
| Income Tax | 7 | 5 | 43 | -193 | 77 |
| Net Income Continuous | -618 | -2,546 | -1,198 | 498 | -3,140 |
| Net Income | $-618 | $-2,546 | $-1,198 | $498 | $-3,140 |
| EPS Basic Total Ops | -0.12 | -0.51 | -0.24 | 0.12 | -0.66 |
| EPS Basic Continuous Ops | -0.12 | -0.51 | -0.24 | 0.12 | -0.66 |
| EPS Diluted Total Ops | -0.12 | -0.51 | -0.24 | 0.12 | -0.66 |
| EPS Diluted Continuous Ops | -0.12 | -0.51 | -0.24 | 0.12 | -0.66 |
| EBITDA(a) | $1,330 | $-372 | $1,111 | $2,305 | $-837 |